Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Analytical Science, Bioprocessing - Upstream & Downstream, Biosimilars, Business Practice, Clinical Trials, Formulation, Ingredients, Drug Delivery, Small Molecules, Advanced Medicine, Quality & Compliance, Standards & Regulation, Technology and Equipment, Bioprocessing - Single Use Systems, Trends & Forecasts, Dosage Forms

Early stage product development using laser diffraction analysis

Using laser diffraction particle size analysis to support early stage product development

Abstract

Measuring particle size at an early stage in development is therefore of significant benefit to researchers who need to engineer specific product attributes.

Introduction

Particle size and size distribution are often important parameters in defining product performance. Particle size measurement can be used as a tool to predict and control properties such as product stability, uniformity, flowability and appearance, and can also help with understanding the processability of a new material. Measuring particle size at an early stage in development is therefore of significant benefit to researchers who need to engineer specific product attributes.

One of the challenges associated with carrying out particle size distribution measurements during early development is that the amount of material available may be limited. The ability to measure small volume samples is therefore important. However, it is also important to consider how the selected measurement method can be scaled up to handle larger sample quantities during the later stages of development and production. This allows any specifications set at an early stage to be carried forward.

Enjoy our FREE content!

Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE and always will be!

Login if you already created an account

Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine
Register

Or Login as a Guest or via Social Media

Related White Papers

Effective Removal of mAb Aggregate Using Ca++Pure-HA® Media with Potassium Salts

| Contributed by Tosoh

Protein stability analysis technologies for the biopharmaceutical industry

| Contributed by Malvern Panalytical

Technology for combating counterfeit medicine

| Contributed by Malvern Panalytical

Newsletter

Send me the latest from The Medicine Maker.

Sign up now

Related Articles

Manufacture

Strokes of Genius: The Innovation Awards 2018

| Stephanie Sutton

Manufacture

The New Antibody Formats on the Block

| Patrick Endres

Manufacture

All Eyes on E&Ls

| Stephanie Sutton

Most Popular

Register here

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register

December Issue of The Medicine Maker